Status:
COMPLETED
Clinical Characteristics and Outcomes of Pediatric COVID-19
Lead Sponsor:
University of Calgary
Conditions:
COVID-19
SARS-CoV-2 Infection
Eligibility:
All Genders
Up to 18 years
Brief Summary
Rationale: The clinical manifestations of SARS-CoV-2 infection in children are poorly characterized. Preliminary findings indicate that they may be atypical. There is a need to identify the spectrum o...
Detailed Description
Pediatric COVID-19: The characteristics of pediatric 2019 novel coronavirus disease (COVID-19) are not yet well understood. Preliminary findings indicate that atypical presentations of COVID-19 occur ...
Eligibility Criteria
Inclusion
- \< 18 years-old, and
- Present to a participating ED for care, and
- Undergo SARS-CoV-2 testing.
Exclusion
- 1\) Refusal to participate (no informed consent)
Key Trial Info
Start Date :
March 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 5 2022
Estimated Enrollment :
10610 Patients enrolled
Trial Details
Trial ID
NCT04330261
Start Date
March 18 2020
End Date
April 5 2022
Last Update
May 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary/Alberta Children's Hospital
Calgary, Alberta, Canada, T3B 6A8